Journal: Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
Fellow : Jirawat B.
9.00 – 10.00 a.m.
I.D. Conference Room, 5th floor, Bhumisiri mangkhalanusorn building
For more, please visit
http://www.idchula.org/_____________________________
นพ.จิรวัฒน์ บุพพันเหรัญ
Jirawat Buppanharun, MD
